Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Clinical trial NCT06684327 · RECRUITING

Trial details

NCT number: NCT06684327
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Paget Disease, Extramammary Rhabdomyosarcoma Testicular Cancer Penile Cancer Urachal Cancer

Start date: 2024-11-30
Primary completion: 2026-12-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.